Bio-IT World February 9, 2021
Allison Proffitt

The computational biology team at St. Jude has published the latest on GenomePaint, one of the visualization features in the St. Jude Cloud platform, in the January issue of Cancer Cell.

GenomePaint is a web-based, interactive visualization platform for whole-genome, whole-exome, transcriptome, epigenome and 3D-genome architecture of tumor samples. Its use, outlined in the Cancer Cell paper (10.1016/j.ccell.2020.12.011), captures the inter-relatedness between DNA variations and RNA expression, supporting in-depth exploration of both individual cancer genomes and full cohorts.

The development of GenomePaint began in 2017 when a research team led by Dr. Zhang was compiling pan-pediatric cancer genomic landscapes for the NCI TARGET project (Clay McLeod mentioned it nearly a year ago while giving Bio-IT World updates on St....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article